Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroprocaine vs Ropivacaine for Unplanned C-Section
NCT02919072Phase 3Terminated
- Sponsor
- Sintetica
- Start
- Oct 2016
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of chloroprocaine in unplanned cesarean section (2 arms), sponsored by Sintetica. Primary endpoint: Time to the Onset of Anaesthesia. Started Oct 2016; status: terminated.
02
Drugs
chloroprocaine
03
Conditions
unplanned cesarean section
Beyond the preview
Go deeper on NCT02919072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02919072.